http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-012878-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 1998-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2000-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-012878-A1 |
| titleOfInvention | A COMPOUND DERIVED FROM 5'-DEOXICITIDINE, ITS USE, A PROCESS TO MANUFACTURE IT, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND IT, AND A KIT THAT INCLUDES SUCH COMPOSITION. |
| abstract | Compounds derived from 5'-deoxycytidine represented by the general formula I, in which R1 is a hydrogen atom or a group easily hydrolyzable under physiological conditions; R2 is a hydrogen atom or a -CO-OR4 group, where R4 is a linear or branched, saturated or unsaturated hydrocarbon group consisting of one to fifteen carbon atoms, or a group of formula - (CH2) nY (where Y is cyclohexyl or phenyl; n is an integer from 0 to 4); R3 is a hydrogen, bromine, iodine or cyano atom, a C1-4 alkyl group, (which may be substituted by halogen atom (s)), a vinyl oethynyl group (which may be substituted by halogen atom (s) , C1-4alkyl, cycloalkyl, aralkyl, or an aromatic ring that may have one or more heteroatom (s)), or an aralkyl group that may be substituted, for use in medical therapy, especially antitumor therapy. A process for manufacturing them, pharmaceutical compositions comprising them, kits comprising such compositions, and the use of the compounds for the manufacture of a medicament for the treatment of tumors. |
| priorityDate | 1997-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.